|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R92.8 |
Other abnormal and inconclusive findings on diagnostic imaging of breast
|
R928 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 64.90%
|
20.63%
|
6.82%
|
3.07%
|
1.56%
|
0.96%
|
0.61%
|
0.41%
|
0.28%
|
0.23%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R92.8*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
77065
|
DX MAMMO INCL CAD UNI |
171,708
|
171,739
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
163,309
|
163,311
|
|
76642
|
ULTRASOUND BREAST LIMITED |
129,767
|
130,240
|
|
77066
|
DX MAMMO INCL CAD BI |
54,874
|
54,874
|
|
76641
|
ULTRASOUND BREAST COMPLETE |
27,907
|
28,186
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
26,715
|
64,526
|
|
A4648
|
IMPLANTABLE TISSUE MARKER |
14,560
|
17,033
|
|
19083
|
BX BREAST 1ST LESION US IMAG |
13,799
|
13,803
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
9,298
|
10,722
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
9,239
|
9,259
|
|
19081
|
BX BREAST 1ST LESION STRTCTC |
8,453
|
8,454
|
|
88360
|
TUMOR IMMUNOHISTOCHEM/MANUAL |
8,185
|
20,704
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
7,121
|
16,301
|
|
C8908
|
MRI W/O FOL W/CONT, BREAST, |
5,336
|
5,337
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,568
|
3,573
|
|
A9585
|
GADOBUTROL INJECTION |
3,167
|
221,339
|
|
77067
|
SCR MAMMO BI INCL CAD |
2,866
|
2,866
|
|
88361
|
TUMOR IMMUNOHISTOCHEM/COMPUT |
2,681
|
6,176
|
|
77063
|
BREAST TOMOSYNTHESIS BI |
2,428
|
2,428
|
|
77080
|
DXA BONE DENSITY AXIAL |
2,295
|
2,295
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R92.8 related to the following DRG Codes:
600-601
|
